- Presentations
- 2
- Markets
- 1
Cyramza is a brand of Ramucirumab marketed by Eli Lilly, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Ramucirumab
- Brand owner
- Eli Lilly
- Registered in
- United States
- Strengths and forms
- 100 mg/10 mL injection, 500 mg/50 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Cyramza 100 mg/10 mL injectionIntravenous Cold chain | Eli Lilly | US FDA | Available on request |
| Cyramza 500 mg/50 mL injectionIntravenous Cold chain | Eli Lilly | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Cyramza
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.